Clinical Trial Detail

NCT ID NCT03934840
Title Phase 2 of Carbo, Taxel and Abi in Metastatic Castration Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Masonic Cancer Center, University of Minnesota
Indications

prostate cancer

Therapies

Abiraterone + Cabazitaxel + Carboplatin + Prednisone

Age Groups: senior adult

No variant requirements are available.